Public Profile

OptiNose, Inc.

OptiNose, Inc., a pioneering biopharmaceutical company headquartered in the United States, focuses on innovative solutions for patients suffering from chronic sinusitis and other nasal conditions. Founded in 2010, OptiNose has made significant strides in the industry, particularly with its unique delivery systems that enhance the efficacy of medications. The company’s flagship products, including the Xhance nasal spray, leverage advanced technology to improve drug absorption and patient compliance. With a commitment to addressing unmet medical needs, OptiNose has established a strong market position, recognised for its contributions to the field of nasal therapeutics. As it continues to expand its operational reach, OptiNose remains dedicated to transforming the treatment landscape for patients worldwide.

DitchCarbon Score

How does OptiNose, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

13

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

2

Industry Benchmark

OptiNose, Inc.'s score of 13 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

OptiNose, Inc.'s reported carbon emissions

OptiNose, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives related to climate commitments. Without specific emissions figures or defined goals, it is challenging to assess their environmental impact or progress in reducing carbon emissions. The absence of data suggests that OptiNose may still be in the early stages of developing a comprehensive climate strategy. As the industry increasingly prioritises sustainability, it will be important for OptiNose to establish clear commitments and measurable targets to align with global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. OptiNose, Inc.'s primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. OptiNose, Inc. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

OptiNose, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Sanofi

FR
Chemicals nec
Updated 1 day ago

Sumitomo Pharma America, Inc.

US
Chemicals nec
Updated 4 days ago

Chiesi Farmaceutici

IT
Medical, precision and optical instruments, watches and clocks (33)
Updated 1 day ago

Chiesi Ltd.

GB
Chemicals nec
Updated 4 days ago
DitchCarbon Score

Teva Pharmaceuticals

IL
Chemicals nec
Updated 3 days ago

Intersect ENT, Inc.

US
Health and social work services (85)
Updated 4 days ago
DitchCarbon Score

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers